Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by XX% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2023 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by XX% in 2023, of which the U.S. economy will grow by about XX%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2023. However, China's economic growth has slowed down. The 2023 government work report shows that the expected target of economic growth is set at about XX%.
According to research, China has set a growth rate of about XX%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2023, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
VIC Research released the 《Global Anti-Counterfeit Packaging for Healthcare Market Segment Research Report 2023》, which aims to sort out the development status and trends of the Anti-Counterfeit Packaging for Healthcare industry at home and abroad, estimate the overall market scale of the Anti-Counterfeit Packaging for Healthcare industry and the market share of major countries, Anti-Counterfeit Packaging for Healthcare industry, and study and judge the downstream market demand of Anti-Counterfeit Packaging for Healthcare through systematic research, Analyze the competition pattern of Anti-Counterfeit Packaging for Healthcare, so as to help solve the pain points of various stakeholders in Anti-Counterfeit Packaging for Healthcare industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2019-2029) of Anti-Counterfeit Packaging for Healthcare Market by VIC Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Anti-Counterfeit Packaging for Healthcare Market?
3M Company
Applied Dna Sciences, Inc
E. I. Dupont
Sicpa Holding SA
Zebra Technologies Corporation
Trutag Technologies Inc
CCL Industries Inc
Avery Dennison Corporation
Shiner International, Inc
R. R. Donnelley & Sons Company
Impinj, Inc
Essentra Plc
Major Type of Anti-Counterfeit Packaging for Healthcare Covered in VIC Research report:
Invisible Printing
Embedded Image
Digital Watermarks
Hidden Marks
Other
Application Segments Covered in VIC Research Market
Retail Chains
Internet Pharmacies
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Anti-Counterfeit Packaging for Healthcare Market Segment Research Report 2023
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Anti-Counterfeit Packaging for Healthcare Market by Value
2.2.1 Global Anti-Counterfeit Packaging for Healthcare Revenue by Type
2.2.2 Global Anti-Counterfeit Packaging for Healthcare Market by Value
2.3 Global Anti-Counterfeit Packaging for Healthcare Market by Sales
2.3.1 Global Anti-Counterfeit Packaging for Healthcare Sales by Type
2.3.2 Global Anti-Counterfeit Packaging for Healthcare Market by Sales
3. The Major Driver of Anti-Counterfeit Packaging for Healthcare Industry
3.1 Historical & Forecast Global Anti-Counterfeit Packaging for Healthcare Sales and Revenue (2019-2029)
3.2 Largest Application for Anti-Counterfeit Packaging for Healthcare (2019-2029)
3.3 The Major Downstream Company in China Market 2023
4. Global and Regional Anti-Counterfeit Packaging for Healthcare Market
4.1 Regional Market Size in Terms of Sales (2023 & 2029)
4.2 Regional Market Share in Terms of Revenue (2023 & 2029)
4.3 Concentration Ratio (CR5& CR10) of Anti-Counterfeit Packaging for Healthcare Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
5.1 Current and Estimated Sales Breakdown by Type (2019-2029)
5.2 Current and Estimated Sales Breakdown by Application (2019-2029)
5.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
5.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
6. Europe Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
6.1 Current and Estimated Sales Breakdown by Type (2019-2029)
6.2 Current and Estimated Sales Breakdown by Application (2019-2029)
6.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
6.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
7. China Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
7.1 Current and Estimated Sales Breakdown by Type (2019-2029)
7.2 Current and Estimated Sales Breakdown by Application (2019-2029)
7.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
7.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
8. Japan Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
8.1 Current and Estimated Sales Breakdown by Type (2019-2029)
8.2 Current and Estimated Sales Breakdown by Application (2019-2029)
8.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
8.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
9. India Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
9.1 Current and Estimated Sales Breakdown by Type (2019-2029)
9.2 Current and Estimated Sales Breakdown by Application (2019-2029)
9.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
9.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
10. Korea Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
10.1 Current and Estimated Sales Breakdown by Type (2019-2029)
10.2 Current and Estimated Sales Breakdown by Application (2019-2029)
10.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
10.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
11. Southeast Asia Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
11.1 Current and Estimated Sales Breakdown by Type (2019-2029)
11.2 Current and Estimated Sales Breakdown by Application (2019-2029)
11.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
11.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
12. South America Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
12.1 Current and Estimated Sales Breakdown by Type (2019-2029)
12.2 Current and Estimated Sales Breakdown by Application (2019-2029)
12.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
12.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
13. Global Anti-Counterfeit Packaging for Healthcare Average Price Trend
13.1 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in US (2019-2023)
13.2 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in Europe (2019-2023)
13.3 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in China (2019-2023)
13.4 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in Japan (2019-2023)
13.5 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in India (2019-2023)
13.6 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in Korea (2019-2023)
13.7 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in Southeast Asia (2019-2023)
13.8 Market Price for Each Type of Anti-Counterfeit Packaging for Healthcare in South America (2019-2023)
14. Industrial Chain (Impact of COVID-19)
14.1 Anti-Counterfeit Packaging for Healthcare Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Anti-Counterfeit Packaging for Healthcare
15. Anti-Counterfeit Packaging for Healthcare Competitive Landscape
15.1 3M Company
15.1.1 3M Company Company Profiles
15.1.2 3M Company Product Introduction
15.1.3 3M Company Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.1.4 Strategic initiatives
15.2 Applied Dna Sciences, Inc
15.2.1 Applied Dna Sciences, Inc Company Profiles
15.2.2 Applied Dna Sciences, Inc Product Introduction
15.2.3 Applied Dna Sciences, Inc Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.2.4 Strategic initiatives
15.3 E. I. Dupont
15.3.1 E. I. Dupont Company Profiles
15.3.2 E. I. Dupont Product Introduction
15.3.3 E. I. Dupont Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.3.4 Strategic initiatives
15.4 Sicpa Holding SA
15.4.1 Sicpa Holding SA Company Profiles
15.4.2 Sicpa Holding SA Product Introduction
15.4.3 Sicpa Holding SA Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.4.4 Strategic initiatives
15.5 Zebra Technologies Corporation
15.5.1 Zebra Technologies Corporation Company Profiles
15.5.2 Zebra Technologies Corporation Product Introduction
15.5.3 Zebra Technologies Corporation Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.5.4 Strategic initiatives
15.6 Trutag Technologies Inc
15.6.1 Trutag Technologies Inc Company Profiles
15.6.2 Trutag Technologies Inc Product Introduction
15.6.3 Trutag Technologies Inc Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.6.4 Strategic initiatives
15.7 CCL Industries Inc
15.7.1 CCL Industries Inc Company Profiles
15.7.2 CCL Industries Inc Product Introduction
15.7.3 CCL Industries Inc Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.7.4 Strategic initiatives
15.8 Avery Dennison Corporation
15.8.1 Avery Dennison Corporation Company Profiles
15.8.2 Avery Dennison Corporation Product Introduction
15.8.3 Avery Dennison Corporation Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.8.4 Strategic initiatives
15.9 Shiner International, Inc
15.9.1 Shiner International, Inc Company Profiles
15.9.2 Shiner International, Inc Product Introduction
15.9.3 Shiner International, Inc Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.9.4 Strategic initiatives
15.10 R. R. Donnelley & Sons Company
15.10.1 R. R. Donnelley & Sons Company Company Profiles
15.10.2 R. R. Donnelley & Sons Company Product Introduction
15.10.3 R. R. Donnelley & Sons Company Anti-Counterfeit Packaging for Healthcare Sales, Revenue (2019-2023)
15.10.4 Strategic initiatives
15.11 Impinj, Inc
15.12 Essentra Plc
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Anti-Counterfeit Packaging for Healthcare Industry (Volume)
Figure 2. Anti-Counterfeit Packaging for Healthcare Sales by Regions in 2023
Figure 3. Regional Market Share in Terms of Revenue (2023&2029)
Figure 4. The Top 10 and 5 Players Market Share by Anti-Counterfeit Packaging for Healthcare Revenue in 2023
Figure 5. US Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Anti-Counterfeit Packaging for Healthcare Sales (2019-2029)
Figure 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Anti-Counterfeit Packaging for Healthcare Revenue, by Type (Million USD) (2019-2029)
Table 4. Anti-Counterfeit Packaging for Healthcare Sales, by Type (K Unit) (2019-2029)
Table 5. Anti-Counterfeit Packaging for Healthcare Sales (K Unit) by Application (2019-2029)
Table 6. Anti-Counterfeit Packaging for Healthcare Sales (Million USD) by Application (2019-2029)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2023)
Table 9. Regional Market Share in Terms of Revenue (2023&2029)
Table 10. Ranking of Global Top Anti-Counterfeit Packaging for Healthcare Companies by Revenue, Concentration Ratio in 2023
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 13. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 14. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 15. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 19. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 20. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 21. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 30. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 31. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 32. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 36. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 37. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 38. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 42. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 44. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Anti-Counterfeit Packaging for Healthcare Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 48. Table Current and Estimated Sales Breakdown by Type (2019-2029)
Table 49. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in US (2019-2023)
Table 53. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in Europe (2019-2023)
Table 54. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in China (2019-2023)
Table 55. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in Japan (2019-2023)
Table 56. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in India (2019-2023)
Table 57. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in Korea (2019-2023)
Table 58. Market Price (USD/Unit) for Each Type of Anti-Counterfeit Packaging for Healthcare in Southeast Asia (2019-2023)
Table 59. Key Downstream Customer in Each Application Field
Table 60. 3M Company Profiles
Table 61. 3M Company Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 62. 3M Company Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 63. 3M Company Strategic initiatives
Table 64. Applied Dna Sciences, Inc Profiles
Table 65. Applied Dna Sciences, Inc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 66. Applied Dna Sciences, Inc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 67. Applied Dna Sciences, Inc Strategic initiatives
Table 68. E. I. Dupont Profiles
Table 69. E. I. Dupont Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 70. E. I. Dupont Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 71. E. I. Dupont Strategic initiatives
Table 72. Sicpa Holding SA Profiles
Table 73. Sicpa Holding SA Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 74. Sicpa Holding SA Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 75. Sicpa Holding SA Strategic initiatives
Table 76. Zebra Technologies Corporation Profiles
Table 77. Zebra Technologies Corporation Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 78. Zebra Technologies Corporation Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 79. Zebra Technologies Corporation Strategic initiatives
Table 80. Trutag Technologies Inc Profiles
Table 81. Trutag Technologies Inc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 82. Trutag Technologies Inc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 83. Trutag Technologies Inc Strategic initiatives
Table 84. CCL Industries Inc Profiles
Table 85. CCL Industries Inc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 86. CCL Industries Inc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 87. CCL Industries Inc Strategic initiatives
Table 88. Avery Dennison Corporation Profiles
Table 89. Avery Dennison Corporation Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 90. Avery Dennison Corporation Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 91. Avery Dennison Corporation Strategic initiatives
Table 92. Shiner International, Inc Profiles
Table 93. Shiner International, Inc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 94. Shiner International, Inc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 95. Shiner International, Inc Strategic initiatives
Table 97. R. R. Donnelley & Sons Company Profiles
Table 98. R. R. Donnelley & Sons Company Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 99. R. R. Donnelley & Sons Company Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 100. R. R. Donnelley & Sons Company Strategic initiatives
Table 101. Impinj, Inc Profiles
Table 102. Impinj, Inc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 103. Impinj, Inc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 104. Impinj, Inc Strategic initiatives
Table 105. Essentra Plc Profiles
Table 106. Essentra Plc Anti-Counterfeit Packaging for Healthcare Product Introduction
Table 107. Essentra Plc Anti-Counterfeit Packaging for Healthcare Sales (Unit), Revenue (Million USD) (2019-2023)
Table 108. Essentra Plc Strategic initiatives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
